PTC Therapeutics, Inc. (PTCT)
71.22
+1.64
(+2.36%)
USD |
NASDAQ |
Apr 08, 11:22
PTC Therapeutics Cash from Investing (TTM) : -861.98M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Insmed, Inc. | -64.58M |
| Sarepta Therapeutics, Inc. | 69.64M |
| Keros Therapeutics, Inc. | -1.551M |
| Madrigal Pharmaceuticals, Inc. | 32.32M |
| Protagonist Therapeutics, Inc. | -49.33M |